Contraception News and Research

Latest Contraception News and Research

Health and development groups applaud Clinton speech; call for action

A broad coalition of organizations representing millions of Americans applauded today's statement by Secretary of State Hillary Clinton that the United States unequivocally supports the worldwide consensus that achieving universal access to reproductive health is critical for individual health, family well-being, broader economic development and a healthy planet.

9 Jan 2010

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Gilead Sciences, Inc. today announced that a Phase II clinical trial of its investigational integrase inhibitor-based, once-daily, fixed-dose “Quad” regimen of elvitegravir, GS 9350 and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV-1 infection met its primary objective.

7 Jan 2010

Discovery of inhibitory hormone may yield new treatments for cancer and other diseases

Nearly 10 years after the discovery that birds make a hormone that suppresses reproduction, University of California, Berkeley, neuroscientists have established that humans make it too, opening the door to development of a new class of contraceptive and possible treatments for cancer or other diseases.

23 Dec 2009

SenoRx wins patent infringement case

Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the jury in the patent infringement lawsuit against SenoRx brought by Hologic, Cytyc Corp., and Hologic L.P., Inc. in the U.S. District Court for the Northern District of California has returned a verdict in favor of SenoRx.

22 Dec 2009

Teens, contraception and unplanned pregnancy

Nearly all unmarried young adults ages 18-29 believe pregnancy is something that should be planned (94% of men and 86% of women) and say that it is important to avoid pregnancy in their lives right now (86% of men and 88% of women), according to new research released by The National Campaign to Prevent Teen and Unplanned Pregnancy.

15 Dec 2009

Catholics for Choice's statement on restriction of abortion coverage

"Today, Senator Ben Nelson (D-Nebraska) put the policy priorities of the U.S. Catholic bishops before the needs of women nationwide. Originally, Senator Nelson maintained that the abortion language in the healthcare bill was not a make-or-break factor in his vote.

8 Dec 2009

China life science companies receive 'Most Promising Company' awards

The 7th ChinaBio® Investor Forum, held December 2-3, 2009 in Tianjin, concluded a successful meeting by giving “Most Promising Company” awards to two young China life science companies.

7 Dec 2009

Doubling of global investments in family planning, birth control could cut maternal, newborn deaths, report says

By doubling investments in family planning and birth control, developing countries could nearly halve newborn deaths and reduce maternal deaths by 70 percent, a new report said Thursday, Reuters reports.

4 Dec 2009

Health Policy Research Roundup

UCLA Center For Health Policy Research: Health Disparities Among California's Nearly Four Million Low-Income Nonelderly Adult Women - Using data from the 2007 California Health Interview Survey, the authors of this policy brief compare low-income women, ages 18-64, to others. The report finds the low-income women are four times more likely to report fair or poor health and are more likely to report a health condition that interferes with basic physical activities, such as walking or climbing stairs.

4 Dec 2009

Reproductive Health Matters' November issue focuses on criminalisation

Elsevier announced today the publication of the November issue of Reproductive Health Matters. Articles in the issue look at criminalisation in relation to a range of global issues: rape and sexual violence; female genital mutilation; selling and buying sex; provision and use of modern contraception and induced abortion; homosexuality, and HIV transmission.

4 Dec 2009

More investment in family planning and pregnancy-related care will reduce maternal and newborn deaths

Maternal deaths in developing countries could be slashed by 70% and newborn deaths cut nearly in half if the world doubled investment in family planning and pregnancy-related care, shows a new report by the Guttmacher Institute and UNFPA, the United Nations Population Fund. Currently, more than half a million maternal deaths and 3.5 million newborn deaths, many of them easily preventable, occur each year in developing countries.

4 Dec 2009

Bishop-endorsed healthcare system can undermine medical treatments and preventative measures

If the Catholic bishops have their way, many medical treatments and preventative measures we take for granted may be under threat. The pressure that the US bishops have brought to bear on the debate over healthcare reform has been widely reported.

3 Dec 2009

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

2 Dec 2009

IPS examines next year's UNGASS on MDGs, improvements in maternal health

Inter Press Service reports that the September 2010 U.N. Generally Assembly meeting will feature a three-day special session (UNGASS) on the Millennium Development Goals (MDGs).

24 Nov 2009

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

24 Nov 2009

Misconceptions about contraception contribute to lack of family-planning n Uganda

University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception.

24 Nov 2009

UNFPA report highlights relationship between family planning, women's health and climate change

"Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change," according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).

19 Nov 2009

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need.

17 Nov 2009

Results of Phase III clinical trials of flibanserin for treatment of HSDD in pre-menopausal women released

Data from pivotal Phase III clinical trials demonstrate that flibanserin 100mg increased the number of satisfying sexual events (SSE) and sexual desire (the co-primary endpoints) while decreasing the distress associated with Hypoactive Sexual Desire Disorder (HSDD).

16 Nov 2009

FDA approves Lysteda for treating menorrhagia

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.

16 Nov 2009

Contraception News and Research

Latest Contraception News and Research

Health and development groups applaud Clinton speech; call for action

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Discovery of inhibitory hormone may yield new treatments for cancer and other diseases

SenoRx wins patent infringement case

Teens, contraception and unplanned pregnancy

Catholics for Choice's statement on restriction of abortion coverage

China life science companies receive 'Most Promising Company' awards

Doubling of global investments in family planning, birth control could cut maternal, newborn deaths, report says

Health Policy Research Roundup

Reproductive Health Matters' November issue focuses on criminalisation

More investment in family planning and pregnancy-related care will reduce maternal and newborn deaths

Bishop-endorsed healthcare system can undermine medical treatments and preventative measures

New data demonstrating the strength of Novartis' hematology portfolio to be presented

IPS examines next year's UNGASS on MDGs, improvements in maternal health

Lysteda tablets to treat menorrhagia approved by the FDA

Misconceptions about contraception contribute to lack of family-planning n Uganda

UNFPA report highlights relationship between family planning, women's health and climate change

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

Results of Phase III clinical trials of flibanserin for treatment of HSDD in pre-menopausal women released

FDA approves Lysteda for treating menorrhagia

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in